Walid K. Chatila

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract Cancer

  Clinical Cancer Research · 2026-06-26

• Characterization of antibody-drug conjugate target antigen expression in patients with biliary tract cancer.

  Journal of Clinical Oncology · 2026-05-28

• Tracking genomic evolution in <i>ERBB2</i> -altered biliary tract cancer through longitudinal tumor profiling.

  Journal of Clinical Oncology · 2026-05-27

• Genomic correlates of leptomeningeal disease after brain metastasis resection.

  Journal of Clinical Oncology · 2026-05-27

• Clinical impact of <i>MSH3</i> loss-of-function alterations in patients treated with immune checkpoint blockade across cancer types.

  Journal of Clinical Oncology · 2026-05-27

• Genomic and biomarker landscape of MTAP deficiency in gastrointestinal cancers.

  Journal of Clinical Oncology · 2026-05-27

• An actionable machine learning–driven clinicogenomic model as a predictor of brain metastasis risk in breast cancer.

  Journal of Clinical Oncology · 2026-05-27

• Functional assessment of polymerase proofreading variants to define sensitivity to immune checkpoint blockade (ICB) pan-cancer.

  Journal of Clinical Oncology · 2026-05-27

• Association of genomic and clinical factors with outcomes with front-line chemoimmunotherapy in patients with advanced biliary tract cancer.

  Journal of Clinical Oncology · 2026-05-27

• Abstract 2116: Genomic landscape of 1007 pan-cancer brain metastases.

  Cancer Research · 2026-04-03

• Abstract 5063: Ancestry-linked, stage-specific delay to tertiary care is associated with survival differences in colorectal cancer

  Cancer Research · 2026-04-03

• Abstract 3226: FOXA1 alterations drive endocrine therapy resistance through unique transcriptional and epigenomic programs in breast cancer

  Cancer Research · 2026-04-03

• Abstract 1024: CIN signatures as biomarkers of drug sensitivity: Real-world evidence from DNA targeted sequencing data

  Cancer Research · 2026-04-03

• Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Gastroesophageal Adenocarcinoma

  JCO Precision Oncology · 2026-04-01

• Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial

  Nature Medicine · 2026-03-25 · 3 citations

• 127P Distant metastasis velocity as prognostic markers after oligometastatic progression in non-small cell lung cancer

  ESMO Open · 2026-03-17

• POLQ-driven repair scars shape the immunogenic landscape of homologous recombination-deficient pancreatic cancer

  bioRxiv (Cold Spring Harbor Laboratory) · 2026-03-17

• Genomic landscape and clinical outcomes of MDM2 amplifications in biliary tract cancers.

  Journal of Clinical Oncology · 2026-01-10

• Supplementary Video 3 from GABA Regulates Electrical Activity and Tumor Initiation in Melanoma

  2025-12-12

• Supplementary Table 1 from GABA Regulates Electrical Activity and Tumor Initiation in Melanoma

  2025-12-12